Fjell, Anders M. http://orcid.org/0000-0003-2502-8774
Sørensen, Øystein http://orcid.org/0000-0003-0724-3542
Wang, Yunpeng http://orcid.org/0000-0001-9831-1090
Amlien, Inge K. http://orcid.org/0000-0002-8508-9088
Baaré, William F. C. http://orcid.org/0000-0002-1810-7266
Bartrés-Faz, David http://orcid.org/0000-0001-6020-4118
Bertram, Lars
Boraxbekk, Carl-Johan http://orcid.org/0000-0002-4458-6475
Brandmaier, Andreas M. http://orcid.org/0000-0001-8765-6982
Demuth, Ilja http://orcid.org/0000-0002-4340-2523
Drevon, Christian A.
Ebmeier, Klaus P. http://orcid.org/0000-0002-5190-7038
Ghisletta, Paolo http://orcid.org/0000-0001-7731-2406
Kievit, Rogier http://orcid.org/0000-0003-0700-4568
Kühn, Simone http://orcid.org/0000-0001-6823-7969
Madsen, Kathrine Skak http://orcid.org/0000-0001-8884-5902
Mowinckel, Athanasia M.
Nyberg, Lars http://orcid.org/0000-0002-3367-1746
Sexton, Claire E. http://orcid.org/0000-0002-3846-2986
Solé-Padullés, Cristina
Vidal-Piñeiro, Didac http://orcid.org/0000-0001-9997-9156
Wagner, Gerd
Watne, Leiv Otto http://orcid.org/0000-0003-0441-6700
Walhovd, Kristine B. http://orcid.org/0000-0003-1918-1123
Article History
Received: 9 March 2022
Accepted: 31 August 2023
First Online: 5 October 2023
Competing interests
: C.E.S. reports consulting fees from Jazz Pharmaceuticals and is now a full-time employee of the US Alzheimer’s Association. C.A.D. is a cofounder, stock owner, board member and consultant in the contract laboratory Vitas AS, performing personalized analyses of blood biomarkers. The rest of the authors report no competing interests.